Lakewood Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Lakewood Asset Management's BMY Position: Q2 2026 in Review

Lakewood Asset Management increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q2 2026, buying an estimated $24.7K and bringing the position to 30,282 shares worth $1.74M. The position accounts for 0.96% of the portfolio, ranked #30.

Lakewood Asset Management first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.29M in Q4 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Lakewood Asset Management held 30,282 shares of Bristol-Myers Squibb worth $1.74M as of Q2 2026.
• Lakewood Asset Management bought 431 Bristol-Myers Squibb shares in Q2 2026, an estimated $24.7K.
• Bristol-Myers Squibb made up 0.96% of Lakewood Asset Management's portfolio in Q2 2026, its #30 holding.
• Lakewood Asset Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
• Lakewood Asset Management's Bristol-Myers Squibb position peaked at $2.29M in Q4 2022.
• 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Lakewood Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.